Invention Grant
- Patent Title: Enhanced bimatoprost ophthalmic solution
-
Application No.: US13551362Application Date: 2012-07-17
-
Publication No.: US08933127B2Publication Date: 2015-01-13
- Inventor: Chin-Ming Chang , James N. Chang , Rhett M. Schiffman , R. Scott Jordan , Joan-En Chang-Lin
- Applicant: Chin-Ming Chang , James N. Chang , Rhett M. Schiffman , R. Scott Jordan , Joan-En Chang-Lin
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Lorenz Siddiqi
- Main IPC: A61K31/16
- IPC: A61K31/16 ; A61K31/164 ; A61K9/00 ; A61K9/08 ; A61K31/14 ; A61K31/5575 ; A61K47/18 ; A61K31/165
Abstract:
A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.
Public/Granted literature
- US20120316243A1 ENHANCED BIMATOPROST OPHTHALMIC SOLUTION Public/Granted day:2012-12-13
Information query
